Subscribe to Newsletter

Business Practice

Manufacture Business Practice

Biosimilar Backer

| Stephanie Vine

Sitting Down With Cyrus Krakaria, President of Biotechnology for Lupin Limited, Biotech Division, India.

Business & Regulation Technology and Equipment

Medicina Ex Machina

| Roisin McGuigan

Artificial intelligence could have a huge impact on drug discovery.

Business & Regulation Biosimilars

A New Supporter

| Stephanie Vine

Initially, The American College of Rheumatology was cautious about biosimilars, but times have changed.

Discovery & Development Biosimilars

I’m a (Biosimilars) Believer!

| Stephanie Vine

Why does the full potential of biosimilars remain untapped? Four experts weigh in.

Manufacture Business Practice

Trials of a Medicine Maker

Gene and Eva discuss the importance of being cautious when choosing a new supplier.

Business & Regulation Business Practice

Get ‘Em While They’re Young

| Stephanie Vine

Pharmacy students take medicine safety lessons to school classrooms.

Business & Regulation Biosimilars

Business in Brief

| Stephanie Vine

The latest business news and views in pharma.

Manufacture Business Practice

The Medicine Maker Power List 2018

Celebrating the great and the good of pharma.

Manufacture Business Practice

Leading by Learning

Sitting Down With Sophie Kornowski-Bonnet, Global Head, Roche Partnering.

Manufacture Business Practice

Celebrating the Digital Age

| Sophie Kornowski-Bonnet

Digital technologies could transform healthcare.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register